Seegene Inc (096530) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Seegene Inc (096530) has a cash flow conversion efficiency ratio of 0.037x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩37.18 Billion ≈ $25.20 Million USD) by net assets (₩1.00 Trillion ≈ $679.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Seegene Inc - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Seegene Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Seegene Inc debt and liabilities for a breakdown of total debt and financial obligations.
Seegene Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Seegene Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenyang Jinbei Automotive Co Ltd
SHG:600609
|
0.204x |
|
BEIJ.JINGNENG CL.ERG.HYC1
F:BJ6
|
N/A |
|
Canadian General Investments Ltd
TO:CGI
|
-0.003x |
|
Sunway Co Ltd
SHG:603333
|
-0.019x |
|
Pick N Pay Stores Ltd
JSE:PIK
|
0.277x |
|
Harum Energy Tbk PT
JK:HRUM
|
-0.062x |
|
Hangzhou Chinastars Reflective Material Co.Ltd.
SHE:301077
|
N/A |
|
Pearl Global Industries Limited
NSE:PGIL
|
0.215x |
Annual Cash Flow Conversion Efficiency for Seegene Inc (2012–2024)
The table below shows the annual cash flow conversion efficiency of Seegene Inc from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Seegene Inc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩981.48 Billion ≈ $665.13 Million |
₩85.39 Billion ≈ $57.87 Million |
0.087x | -5.57% |
| 2023-12-31 | ₩1.03 Trillion ≈ $698.29 Million |
₩94.93 Billion ≈ $64.33 Million |
0.092x | -66.85% |
| 2022-12-31 | ₩1.15 Trillion ≈ $777.83 Million |
₩319.01 Billion ≈ $216.19 Million |
0.278x | -10.02% |
| 2021-12-31 | ₩1.08 Trillion ≈ $732.85 Million |
₩334.02 Billion ≈ $226.36 Million |
0.309x | -47.98% |
| 2020-12-31 | ₩645.32 Billion ≈ $437.32 Million |
₩383.16 Billion ≈ $259.66 Million |
0.594x | +233.73% |
| 2019-12-31 | ₩152.55 Billion ≈ $103.38 Million |
₩27.14 Billion ≈ $18.39 Million |
0.178x | +62.59% |
| 2018-12-31 | ₩128.03 Billion ≈ $86.76 Million |
₩14.01 Billion ≈ $9.49 Million |
0.109x | +35.27% |
| 2017-12-31 | ₩125.04 Billion ≈ $84.74 Million |
₩10.12 Billion ≈ $6.86 Million |
0.081x | -30.63% |
| 2016-12-31 | ₩141.97 Billion ≈ $96.21 Million |
₩16.56 Billion ≈ $11.22 Million |
0.117x | +612.54% |
| 2015-12-31 | ₩135.09 Billion ≈ $91.55 Million |
₩-3.07 Billion ≈ $-2.08 Million |
-0.023x | -131.84% |
| 2014-12-31 | ₩94.83 Billion ≈ $64.27 Million |
₩6.78 Billion ≈ $4.59 Million |
0.071x | +308.60% |
| 2013-12-31 | ₩84.44 Billion ≈ $57.23 Million |
₩-2.89 Billion ≈ $-1.96 Million |
-0.034x | -139.12% |
| 2012-12-31 | ₩41.94 Billion ≈ $28.42 Million |
₩3.67 Billion ≈ $2.49 Million |
0.088x | -- |
About Seegene Inc
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection … Read more